Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis
Journal of Personalized Medicine · 29.07.2024 · 14 (8) · 802
DOI: 10.3390/jpm14080802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 29.07.2024. Verfasst von Amin Jahanbakhshi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Skull Base Research Center, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran 1997667665, Iran. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Meningiomas are the most prevalent benign intracranial tumors. When they are of the invasive subtypes, i.e., grades II and III, they can recur rapidly and present a real challenge for physicians. This study is focused on the use of stereotactic radiosurgery to manage high-grade meningiomas.
Method
Medline via PubMed was searched from inception to December 2022 to retrieve studies on stereotactic radiation therapy for patients with grade II-III meningiomas. This study was conducted under PRISMA guidelines.
Result
A total of 29 articles involving 1446 patients with grade II-III meningiomas treated with stereotactic radiation therapy were included in the present study. Of these studies, 11 were conducted exclusively on patients with atypical meningiomas (grade II), 1 targeted anaplastic meningiomas (grade III), and 17 articles were carried out on both grade II and III meningiomas. The pooled 1, 2, 3, 5, and 10-year overall survival (OS) of grade II meningiomas was 0.96 [p < 0.01], 0.89 [p = 0.01], 0.90 [p = 0.09], 0.81 [p < 0.01], and 0.66 [p = 0.55], respectively. The pooled 2, 5, and 10-year OS of grade III meningiomas was 0.64 [p = 0.01], 0.41 [p = 0.01], and 0.19 [p < 0.01], respectively.
Conclusions
Although long-term prospective studies are still required, the outcomes of stereotactic radiation therapy appear promising regarding overall outcome and progression-free survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Skull Base Research Center, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran 1997667665, Iran.
- Radiation Oncology Research Center, Iran Cancer Institute, Tehran University of Medical Sciences, Tehran 1997667665, Iran.
- Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
- Radiation Oncology Department, Centre Leon Berard, 69373 Lyon, France.
- Radiation Oncology Unit, S. Luca Hospital, Healthcare Company Tuscany Nord Ovest, 55100 Lucca, Italy.
- Interdisciplinary Department of Medicine, Section of Radiology and Radiation Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.
ORCID-Profile: Amin Jahanbakhshi, Camille Roukoz
Zitieren
APA
Jahanbakhshi, A., Najafi, M., Gomar, M., Ciammella, P., Ruggieri, M. P., Iotti, C., Finocchi Ghersi, S., Serre, A. A., Bardoscia, L., Sardaro, A., Boisbouvier, S., Roukoz, C., & Cozzi, S. (2024). Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine, 14(8), 802. https://doi.org/10.3390/jpm14080802
Vancouver
Jahanbakhshi A, Najafi M, Gomar M, Ciammella P, Ruggieri MP, Iotti C, et al. Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 2024;14(8):802. doi:10.3390/jpm14080802
BibTeX
@article{Jahanbakhshi2024,
author = {Jahanbakhshi, Amin and Najafi, Masoumeh and Gomar, Marzieh and Ciammella, Patrizia and Ruggieri, Maria Paola and Iotti, Cinzia and Finocchi Ghersi, Sebastiano and Serre, Anne-Agathe and Bardoscia, Lilia and Sardaro, Angela and Boisbouvier, Sophie and Roukoz, Camille and Cozzi, Salvatore},
title = {Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {8},
pages = {802},
doi = {10.3390/jpm14080802}
}
EUVIMED